Safety of Twice Daily Sotalol in Patients with Renal Impairment: A Single Center, Retrospective Review.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of atrial fibrillation"
DOI: 10.4022/jafib.2047
Abstract: Background The class III antiarrhythmic sotalol is renally eliminated with a dose-related propensity to cause adverse drug reactions (ADR) potentially leading to life-threatening arrhythmias. Although product labeling recommends once daily dosing in patients with renal… read more here.
Keywords: twice daily; patients renal; therapy; renal impairment ... See more keywords